Table 4.
Scientific evaluation of apps.
| Category | No. | Criteria | Medisafe | MyTherapy | Meds on time | Médi'rappel | SwissMeds | Dosecast | Suivre ma Rx | Rappel de médicament |
|---|---|---|---|---|---|---|---|---|---|---|
| Security and privacy | 1 | Password | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
| (max five points) | 2 | User consent | 1 | 1 | n/a | 1 | 1 | 0 | 0 | 0 |
| 3 | User consent revisable | 1 | 1 | n/a | 1 | 1 | 0 | 0 | 0 | |
| 4 | Erasing of user data | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | |
| 5 | Data collection | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | |
| Subtotal | 4 | 5 | 2 | 3 | 3 | 2 | 2 | 1 | ||
| Quality of health-related | 6 | Aim | 1 | 1 | 1 | 1 | n/a | 1 | 1 | 1 |
| content | 7 | Education | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| (max four points) | 8 | Involvement of healthcare professionals | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| 9 | Trustworthiness, credibility, and quality of the educational information | n/a | n/a | n/a | n/a | 0 | 0 | 0 | 0 | |
| Subtotal | 3 | 1 | 3 | 3 | 0 | 1 | 1 | 1 | ||
| Quality of information | 10 | Certification | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| management of and | 11 | Content author's expertise | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| topic-related | 12 | Evaluation by target population | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| information (max six | 13 | Declaration of interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| points) | 14 | Sources and references | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 15 | Funding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Subtotal | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | ||
| Functionality (max 11 points) | 16 | Reminders: text messages and push notifications | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 17 | Visual feedback | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |
| 18 | Meetings | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 19 | Cloud/synchronization of data on different devices | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | |
| 20 | Access and sharing of different phone functions | n/a | n/a | n/a | n/a | 1 | 1 | 1 | 0 | |
| 21 | Patient file | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 22 | Manual entries and comments | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | |
| 23 | Gamification | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 24 | Support | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | |
| 25 | Refill | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | |
| 26 | Time zone adaptation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Subtotal | 8 | 6 | 4 | 2 | 4 | 6 | 5 | 1 | ||
| Esthetics (max three | 27 | Flexibility | n/a | n/a | n/a | n/a | 1 | 1 | 1 | 0 |
| points) | 28 | Legibility | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| 29 | Customization | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | |
| Subtotal | 1 | 1 | 1 | 0 | 1 | 2 | 2 | 1 | ||
| Advertising (max three | 30 | Advertising | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| points) | Subtotal | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Total points (max 30 points) | 16/27 | 15/27 | 11/25 | 9/27 | 12/29 | 12/30 | 11/30 | 5/30 | ||
| 59% | 56% | 44% | 33% | 41% | 40% | 37% | 17% | |||